Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

HIF-1/2α-IN-2

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T61102 Copy Product Info
🥰Excellent
HIF-1/2α-IN-2 is a selective inhibitor targeting hypoxia-inducible factors 1α and 2α (HIF-1α and HIF-2α). It induces a state of cellular iron deficiency by inhibiting the activity of iron-sulfur cluster assembly protein 2 (ISCA2), thereby reducing HIF-2α synthesis and ultimately triggering ferroptosis. HIF-1/2α-IN-2 is widely used in research related to tumor biology, metabolic regulation, and ischemia.
HIF-1/2α-IN-2
Cas No. 862974-22-9
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$63-In Stock
5 mgPreferential-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
HIF-1/2α-IN-2 is a selective inhibitor targeting hypoxia-inducible factors 1α and 2α (HIF-1α and HIF-2α). It induces a state of cellular iron deficiency by inhibiting the activity of iron-sulfur cluster assembly protein 2 (ISCA2), thereby reducing HIF-2α synthesis and ultimately triggering ferroptosis. HIF-1/2α-IN-2 is widely used in research related to tumor biology, metabolic regulation, and ischemia.
In vitro
HIF-1/2α-IN-2(0-25 μM; 24 h) decreases HIF-2α translation instead of transcription, with a downward trend in VEGFA and POU5F1 (HIF-2α target genes) transcription and insignificant effect on EPAS1 (HIF-2α)[1].
HIF-1/2α-IN-2 (0-100 μM, 24 h) inhibits the production of luciferase driven by the HIF-2α Iron-Responsive Element (IRE) luciferase reporter with an IC50 value of 3.9 μM, to block IRE-dependent translation of HIF-2α[1].
HIF-1/2α-IN-2 (0, 10, 50 μM) protects ISCA2 from Pronase-mediated (4 μg/mL) degradation, and (1.5 μM; 24 h) targets ISCA2 to induce iron and metals accumulation in normoxia 786-0 cells[1].
HIF-1/2α-IN-2 (0-100 μM; 24 h) results ISCA2 inhibition and promotes cell death via ferroptosis[1].
Chemical Properties
Molecular Weight342.35
FormulaC16H11FN4O2S
Cas No.862974-22-9
SmilesFC=1C=CC(=CC1)C2=NN=C(O2)NC3=NC=4C(OC)=CC=CC4S3
Storage & Solubility Information
StorageKeep away from moisture,Keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: HIF-1/2α-IN-2 chemical structure | HIF-1/2α-IN-2 in vitro | HIF-1/2α-IN-2 formula | HIF-1/2α-IN-2 molecular weight